Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial

NCT04678739 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

205

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19
Covid-19 ARDS

Interventions

DRUG: Remdesivir
DRUG: Tocilizumab

Sponsor

M Abdur Rahim Medical College and Hospital

Collaborators

[object Object]
[object Object]
[object Object]